Journal of the Pancreas Open Access

Xanthogranulomatous Pancreatitis Showing Overlapping

Cheeka Veena^* Department of General Surgery, Georgia Institute of Technology, Atlanta, Georgia
^*Correspondence: Cheeka Veena, Department of General Surgery, Georgia Institute of Technology, Atlanta, Georgia, Email:

Received: 14-Nov-2024, Manuscript No. IPP-24-21972; Editor assigned: 18-Nov-2024, Pre QC No. IPP-24-21972 (PQ); Reviewed: 03-Dec-2024, QC No. IPP-24-21972; Revised: 17-Feb-2026, Manuscript No. IPP-24-21972 (R); Published: 24-Feb-2026, DOI: 10.36648/1590-8577.27.1.954

Description

Xanthogranulomatous Pancreatitis (XGP) is a rare and severe form of chronic pancreatitis, characterized by the formation of granulomatous tissue within the pancreas. This condition is typically seen in association with longstanding inflammation and can be difficult to diagnose due to its resemblance to pancreatic cancer or other forms of pancreatitis. The term "xanthogranulomatous" comes from the yellowish appearance of the affected tissue, which results from the accumulation of lipid-laden macrophages (known as xanthoma cells) in the granulomatous lesions.

Etiology and pathophysiology

The exact cause of XGP remains unclear, but it is often associated with prolonged or chronic pancreatitis, typically linked to gallstones, alcohol use, or biliary obstruction. Other factors like infections, autoimmune diseases, or trauma may also play a role. The condition is believed to occur when the pancreatic ducts become obstructed or inflamed, leading to pancreatic tissue damage and the subsequent formation of granulomatous tissue. This granulomatous tissue often contains inflammatory cells, foamy macrophages, and fibrosis, which can eventually replace healthy pancreatic tissue.

Clinical presentation

Patients with XGP typically present with non-specific symptoms, including abdominal pain (usually in the upper abdomen), weight loss, jaundice, and nausea. In some cases, a palpable mass or swelling in the abdomen may be noted. Because the symptoms overlap with those of pancreatic cancer, imaging studies are crucial for differentiating between the two. XGP can lead to complications such as pancreatic pseudocysts, ductal obstruction, or biliary stricture.

Diagnosis

The diagnosis of XGP requires a combination of clinical suspicion, imaging studies, and histopathological examination. Radiological techniques such as CT scans and MRIs often show a mass-like lesion, which can mimic pancreatic cancer or a pancreatic abscess. However, biopsy and histological analysis are necessary for confirmation, revealing the characteristic xanthogranulomatous inflammation.

Treatment

Treatment is typically surgical, with procedures aimed at removing the affected pancreatic tissue or drainage of any pseudocysts. In some cases, medical management with antibiotics or corticosteroids may be indicated to control inflammation. The prognosis varies depending on the extent of the disease, but early diagnosis and intervention generally improve outcomes.